LBF20207PG56
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1746 |
LipidMaps | LMFA03010064 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG56 |
15S-15-methyl Prostaglandin E2 | |
---|---|
Structural Information | |
9-Oxo- (11α,15S) -dihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-oic acid | |
| |
Formula | C21H34O5 |
Exact Mass | 366.240624198 |
Average Mass | 366.49166 |
SMILES | C(=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)[C@](C)(O)CCCCC |
Physicochemical Information | |
15(S)-15-methyl Prostaglandin E2 inhibits gastric acid secretion and consequent ulcer formation. Kimball_FA et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|